Clinical Translation of CNS Aptamer Therapeutics: From Bench to Bedside

• Explore the discovery and validation process steps in developing aptamer-based therapeutics for CNS applications
• Overview of AptaTargets clinical development pathway, including preclinical research as well as Phase I and Phase II clinical trials
• Considering the future direction of Phase III clinical development and the continued advancement of CNS aptamer therapeutics

Speakers:

Macarena Hernandez

CSO

AptaTargets